T cell therapy shows promise in treating aggressive brain cancer
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form ...
Aug 31, 2026
0
40









